Evidence map›Paper›PMID 31677050›Full record

ArticleJournal of medical toxicology : official journal of the American College of Medical Toxicology2020

Assessment of the Utility of the Oral Fluid and Plasma Proteomes for Hydrocodone Exposure.

Brooke L Deatherage Kaiser, Jon M Jacobs, Athena A Schepmoes, Heather M Brewer, Bobbie-Jo M Webb-Robertson, Sandra Valtier, Vikhyat S Bebarta, Joshua N Adkins

Open access · bronzeAbstract read
In one paragraph

Article in Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Brooke L Deatherage KaiserChemical and Biological Signature Sciences Group, Pacific Northwest National Laboratory, Richland, WA, USA.
Jon M JacobsBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA.
Athena A SchepmoesBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA.
Heather M BrewerEnvironmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, WA, USA.
Bobbie-Jo M Webb-RobertsonBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA.
Sandra ValtierScience and Technology, 59th Medical Wing, JBSA-Lackland AFB, San Antonio, TX, USA.
Vikhyat S BebartaUniversity of Colorado School of Medicine, Aurora, CO, USA. Vikhyat.bebarta@ucdenver.edu.ORCID 0000-0001-8816-1199
Joshua N AdkinsBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA.ORCID 0000-0003-0399-0700
Pacific Northwest National Laboratory · US59th Medical Wing · USUniversity of Colorado Denver · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionNon-medical use and abuse of prescription opioids is a growing problem in both the civilian and military communities, with minimal technologies for detecting hydrocodone use. This study explored the proteomic changes that occur in the oral fluid and blood plasma following controlled hydrocodone administration in 20 subjects.

methodsThe global proteomic profile was determined for samples taken at four time points per subject: pre-exposure and 4, 6, or 168 hours post-exposure. The oral fluid samples analyzed herein provided greater differentiation between baseline and response time points than was observed with blood plasma, at least partially due to significant person-to-person relative variability in the plasma proteome.

resultsA total of 399 proteins were identified from oral fluid samples, and the abundance of 118 of those proteins was determined to be significantly different upon metabolism of hydrocodone (4 and 6 hour time points) as compared to baseline levels in the oral fluid (pre-dose and 168 hours).

conclusionsWe present an assessment of the oral fluid and plasma proteome following hydrocodone administration, which demonstrates the potential of oral fluid as a noninvasive sample that may reveal features of hydrocodone in opioid use, and with additional study, may be useful for other opioids and in settings of misuse.

Indexed as

ProteomeProteomicsSubstance Abuse DetectionAdultAnalgesics, OpioidBlood ProteinsChromatography, High Pressure LiquidFemaleHumansHydrocodoneMaleMiddle AgedOpioid-Related DisordersPredictive Value of TestsSalivaSolid Phase ExtractionAnalgesics, OpioidBlood ProteinsHydrocodoneProteomeHydrocodoneOpioidOral fluidPlasmaProteomics

Identifiers

PMID31677050
PMCPMC6942069
OpenAlexW2984472793

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.